Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: The role of respiratory viruses

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2765-2772

  Sangil, A ^a   Calbo, E ^a,c   Robles, A ^a   Benet, S ^a   Viladot, M E ^a   Pascual, V ^a   Cuchi E ^b   Perez J ^b   Barreiro, B ^a   Sanchez B ^a   Torres, J ^a   Canales, L ^a   De Marcos, J A ^a   Garau, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Service of Microbiology   (Spain)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA INTERFERON; C REACTIVE PROTEIN; CORTICOSTEROID; PROCALCITONIN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BACTERIAL PNEUMONIA; BLOOD CULTURE; BORDETELLA PERTUSSIS; CHILL; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLUENZA VIRUS A H1N1; LABORATORY TEST; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEPTIC SHOCK; SEROLOGY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BORDETELLA PERTUSSIS; CHLAMYDOPHILA PNEUMONIAE; COINFECTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEGIONELLA PNEUMOPHILA; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA PNEUMONIAE; PANDEMICS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEASONS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84869143146     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1626-6     Document Type: Article

References (31)

1. File TM (2003) Community-Acquired pneumonia. Lancet 362:1991-2001
2. Garau J, Calbo E (2008) Community-Acquired pneumonia. Lancet 371:455-458
3. Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 44(Suppl 2): S27-S72
4. Templeton KE, Scheltinga SA, Beersma MF et al (2004) Rapid and sensitive method using multiplex real-Time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42:1564-1569
5. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
6. Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-Acquired pneumonia. N Engl J Med 336:243-250
7. Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377-382
8. Templeton KE, Scheltinga SA, van den Eeden WC et al (2005) Improved diagnosis of the etiology of community-Acquired pneumonia with real-Time polymerase chain reaction. Clin Infect Dis 41:345-351
9. Johnstone J, Majumdar SR, Fox JD et al (2008) Viral infection in adults hospitalized with community-Acquired pneumonia: prevalence, pathogens, and presentation. Chest 134:1141-1148
10. Jennings LC, Anderson TP, Beynon KA et al (2008) Incidence and characteristics of viral community-Acquired pneumonia in adults. Thorax 63:42-48
11. Angeles Marcos M, Camps M, Pumarola T et al (2006) The role of viruses in the aetiology of community-Acquired pneumonia in adults. Antivir Ther 11:351-359
12. Johansson N, Kalin M, Tiveljung-Lindell A et al (2010) Etiology of community-Acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 50:202-209
13. Saito A, Kohno S, Matsushima T et al (2006) Prospective multicenter study of the causative organisms of community-Acquired pneumonia in adults in Japan. J Infect Chemother 12:63-69
14. Charles PG, Whitby M, Fuller AJ et al (2008) The etiology of community-Acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 46:1513-1521
15. Hohenthal U, Vainionpää R, Meurman O et al (2008) Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis 40:131-138
16. Hohenthal U, Vainionpää R, Nikoskelainen J et al (2008) The role of rhinoviruses and enteroviruses in community acquired pneumonia in adults. Thorax 63:658-659
17. Diederen BMW, Van Der Eerden MM, Vlaspolder F et al (2009) Detection of respiratory viruses and Legionella spp. by real-Time polymerase chain reaction in patients with community acquired pneumonia. Scand J Infect Dis 41:45-50
18. Lieberman D, Shimoni A, Shemer-Avni Yet al (2010) Respiratory viruses in adults with community-Acquired pneumonia. Chest 138:811-816
19. Chalmers JD, Taylor JK, Singanayagam A et al (2011) Epidemiology, antibiotic therapy, and clinical outcomes in health care-Associated pneumonia: a UK cohort study. Clin Infect Dis 53:107-113
20. Johansson N, Kalin M, Hedlund J (2011) Clinical impact of combined viral and bacterial infection in patients with communityacquired pneumonia. Scand J Infect Dis 43:609-615
21. von Baum H, Schweiger B, Welte T et al (2011) How deadly is seasonal influenza-Associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J 37:1151-1157
22. Murdoch DR, Anderson TP, Beynon KA et al (2003) Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with communityacquired pneumonia. J Clin Microbiol 41:63-66
23. File TM Jr, Marrie TJ (2010) Burden of community-Acquired pneumonia in North American adults. Postgrad Med 122:130-141
24. Percivalle E, Rovida F, Piralla A et al (2008) Rapid typing, subtyping and RNA quantification of influenza virus type A strains in respiratory secretions. New Microbiol 31:319-327
25. Marcos MA, Esperatti M, Torres A (2009) Viral pneumonia. Curr Opin Infect Dis 22:143-147
26. Thompson WW, Shay DK, Weintraub E et al (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186
27. Longtin J, Marchand-Austin A, Winter AL et al (2010) Rhinovirus outbreaks in long-Term care facilities, Ontario, Canada. Emerg Infect Dis 16:1463-1465
28. Ruuskanen O, Lahti E, Jennings LC et al (2011) Viral pneumonia. Lancet 377:1264-1275
29. Gilbert DN (2011) Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 52(Suppl 4):S346-S350
30. Schuetz P, Albrich W, Christ-Crain M et al (2010) Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 8:575-587
31. Gilbert DN (2010) Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 48:2325-2329